Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics Raises $3M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NeoGenomics last week announced it raised $3 million.

Five members of the Ft. Myers, Fla.-based company's board and senior management as well as two existing institutional investors participated in the raise, which was priced at $1.50 per share. A total of 2 million shares of new common stock were issued by NeoGenomics.

No warrants were issued and no placement agent was used in the transaction, the company said. It plans to use proceeds to strengthen its financial position and fund growth initiatives, it said.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.